Close
FINDING CURES TOGETHER<sup>SM</sup>

AACR Annual Meeting 2017

NextGen Stars 

The NextGen Stars program provides an exciting opportunity to increase the visibility of early-career scientists at the AACR Annual Meeting and to support the professional development and advancement of those selected to speak. Six outstanding NextGen Stars will present their work in major sessions at the AACR Annual Meeting 2017. Selections were made through a competitive application process that was limited to AACR Associate Members and AACR Active Members who were at the junior faculty level (not higher than assistant professor or equivalent). 

Congratulations to the 2017 NextGen Stars!

Valsamo Anagnostou, Johns Hopkins Kimmel Comprehensive  Cancer Center, Baltimore, Maryland
Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

Major Symposium
Mechanisms Regulating Immune Checkpoint Therapies
Monday, April 3, 2017, 10:30 a.m.-12:15 p.m.
Room 146, Level 1, Washington Convention Center


Bishoy Faltas, Weill Cornell Medical College, New York, New York
Genomic dissection of the clonal evolution dynamics of chemotherapy-resistant urothelial carcinoma

Recent Advances in Organ Site Research
Bladder Cancer
Wednesday, April 5, 2017, 10:15 a.m.-12:00 p.m.
Room 151, Level 1, Washington Convention Center


Amanda Lund, Oregon Health & Science University, Portland, Oregon
Lymphatic vessels: Balancing immune priming and immune evasion in melanoma

Major Symposium
The Effects of Tumor Microenvironment on Metastasis and Therapy Resistance
Monday, April 3, 2017, 10:30 a.m.-12:15 p.m.
Room 202, Level 2, Washington Convention Center


Nardin Samuel, University of Toronto, Toronto, Ontario, Canada
TP53-mediated human cancer susceptibility is defined by epigenetic dysregulation of microRNA-34A

Major Symposium
Dysregulation of MicroRNAs Leads to Target Therapy
Tuesday, April 4, 2016, 1:00 p.m.-2:45 p.m.
Room 152, Level 1, Washington Convention Center


Mingyang Song, Massachusetts General Hospital, Boston, Massachusetts
Marine Omega-3 polyunsaturated fatty acid and colorectal cancer prevention and treatment

Recent Advances in Prevention Research
Diet and Precision Medicine in Cancer Prevention: The Role of Genetic Background, the Microbiome, and Epigenetic Mechanisms
Monday, April 3, 2017, 10:30 a.m.-12:15 p.m.
Room 145, Level 1, Washington Convention Center


Jesse Zaretsky, University of California, Los Angeles, California
Mechanisms of resistance to anti-PD-1 immunotherapy through interferon pathway mutations

Major Symposium
Mechanisms of Primary and Acquired Resistance to Immunotherapy
Tuesday, April 4, 2017, 10:30 a.m.-12:15 p.m.
Hall D-E, Level 2, Washington Convention Center

View the abstracts of the NextGen Stars' presentations from the AACR Annual Meeting 2016:

Margaret L. Hoang, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Accumulation of somatic mutations in normal and cancerous tissues with age

Major Symposium
Population Genetics Meets Single Cell Analysis
Tuesday, April 19, 2016, 1:00 p.m. - 2:45 p.m.
Room 354, Morial Convention Center


Genevieve Kendall, UT Southwestern Medical Center, Dallas, Texas
Zebrafish models of PAX3-FOXO1 pathogenesis reveal novel targets in human rhabdomyosarcoma

Major Symposium
Pediatric Cancers and Epigenetic Therapies: Promise and Challenges
Wednesday, April 20, 2016, 10:15 a.m. - 12:00 p.m.
Room 354, Morial Convention Center


John Paul Shen, University of California – San Diego, La Jolla, California
A network of deeply conserved synthetic-lethal interactions for exploration of precision cancer therapy

Major Symposium
Modeling the Interface between Cancer Genomics and Drugs
Wednesday, April 20, 2016, 10:15 a.m. - 12:00 p.m.
Room 243, Morial Convention Center


Top of page